The invention relates to fullerene compounds of formula (I); in which X1, X2, X3, X4, X5, YI, Y2, V, W, F, E, R, r, n, p, and q are defined as in the specification. Also disclosed are pharmaceutical compositions containing one of the compounds described above.
该发明涉及
化学式(I)的
富勒烯化合物;其中X1、X2、X3、X4、X5、Y1、Y2、V、W、F、E、R、r、n、p和q的定义如规范中所述。还公开了含有上述化合物之一的药物组合物。